GAMBICORTI, Elena
 Distribuzione geografica
Continente #
NA - Nord America 1.179
EU - Europa 303
AS - Asia 223
OC - Oceania 3
AF - Africa 1
Totale 1.709
Nazione #
US - Stati Uniti d'America 1.176
CN - Cina 153
UA - Ucraina 124
DE - Germania 45
HK - Hong Kong 40
IT - Italia 31
FI - Finlandia 24
SG - Singapore 23
IE - Irlanda 22
GB - Regno Unito 19
CZ - Repubblica Ceca 14
FR - Francia 6
IN - India 6
BE - Belgio 5
NL - Olanda 5
AU - Australia 3
SE - Svezia 3
CA - Canada 2
RO - Romania 2
EE - Estonia 1
HU - Ungheria 1
JP - Giappone 1
MX - Messico 1
RU - Federazione Russa 1
SL - Sierra Leone 1
Totale 1.709
Città #
Fairfield 227
Woodbridge 116
Jacksonville 98
Cambridge 94
Seattle 91
Houston 88
Ashburn 85
Wilmington 82
Ann Arbor 70
Chandler 45
Princeton 42
Hong Kong 40
Beijing 34
Nanjing 27
Dublin 21
Helsinki 20
Brno 14
Shanghai 14
Singapore 14
New York 12
Des Moines 11
Shenyang 11
Jinan 9
Nanchang 9
San Diego 9
San Francisco 9
Changsha 7
Jiaxing 7
Tianjin 7
Hebei 6
Brescia 5
Brussels 5
London 5
Munich 5
Orange 5
Dearborn 4
Florence 4
Milan 4
Verona 4
Haikou 3
Hangzhou 3
Kunming 3
Taizhou 3
Zhengzhou 3
Boardman 2
Canberra 2
Lancaster 2
Ningbo 2
Pune 2
Redwood City 2
San Giuliano Terme 2
Toronto 2
Trento 2
Zuid-Beijerland 2
Acton 1
Ascoli Piceno 1
Budapest 1
Castiglione Delle Stiviere 1
Falkenstein 1
Freetown 1
Fuzhou 1
Guangzhou 1
Hefei 1
Jersey City 1
Kilburn 1
Lanzhou 1
Melbourne 1
Prescot 1
Pullach im Isartal 1
Rende 1
Tallinn 1
Totale 1.412
Nome #
ILM peeling in nontractional diabetic macular edema: review and metanalysis 122
Efficacy and vitreous levels of topical NSAIDs 111
Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration: an overview 103
PEELING OF THE INTERNAL LIMITING MEMBRANE WITH FOVEAL SPARING FOR TREATMENT OF DEGENERATIVE LAMELLAR MACULAR HOLE 103
Controversies over the role of internal limiting membrane peeling during vitrectomy in macular hole surgery 96
Pharmacokinetic and Pharmacodynamic Properties of Anti-VEGF Drugs After Intravitreal Injection 95
Comparison of half-dose photodynamic therapy and 689 nm laser treatment in eyes with chronic central serous chorioretinopathy 95
Aflibercept in wet AMD: specific role and optimal use 93
Heavy silicone oil and intraocular inflammation 93
Heavy and standard silicone oil: intraocular inflammation 92
From the analysis of pharmacologic vitreolysis to the comprehension of ocriplasmin safety 91
Central serous chorioretinopathy: Pathogenesis and management 88
Current trends about inner limiting membrane peeling in surgery for epiretinal membranes 85
Combination of ranibizumab and indomethacin for neovascular age-related macular degeneration: randomized controlled trial 83
FOVEA-SPARING VERSUS COMPLETE INTERNAL LIMITING MEMBRANE PEELING IN VITRECTOMY FOR THE TREATMENT OF MACULAR HOLES 79
Functional and Morphological Changes Following Macular Pucker Surgery After Topical Administration of Indomethacin 0.5%, Bromfenac 0.09%, Nepafenac 0.1%, or Placebo 68
Gene expression analysis identifies two distinct molecular clusters of idiopatic epiretinal membranes 67
Epiretinal Membrane Peeling with Foveal Sparing of the Internai Limiting Membrane: A Pilot Study 60
Comparison of visual and anatomical outcomes of half-dose photodynamic therapy and 689 nm laser treatment (pseudo-PDT) in eyes with chronic central serous chorioretinopathy 54
Foveal sparing internal limiting membrane peeling for Lamellar Macular Hole 54
Prospective Randomized Controlled Trial of Combination Ranibizumab and Indomethacin for Neovascular Age-Related Macular Degeneration 50
Vitreous from idiopathic epiretinal membrane patients induces glial-to-mesenchymal transition in Müller cells 11
Totale 1.793
Categoria #
all - tutte 9.002
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.002


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020452 0 17 17 52 34 53 45 58 58 71 10 37
2020/2021390 4 48 19 38 28 64 37 36 29 43 32 12
2021/2022191 26 17 10 14 1 8 3 18 9 23 14 48
2022/2023141 26 2 6 6 17 32 0 14 25 1 7 5
2023/2024175 15 6 27 8 11 19 7 6 41 3 3 29
2024/202514 14 0 0 0 0 0 0 0 0 0 0 0
Totale 1.793